In contrast to MYC-driven cancers such as neuroblastoma, where RECQL2 has been reported to provide a critical pro-survival function that is necessary for efficient tumor growth and constitutes a candidate therapeutical target [30,31], our data support the previously described function of RECQL2 as a tumor suppressor of the caretaker type [8]. The gene discussed is WRN; the disease is neoplasm.